Use of serum amyloid a gene in diagnosis and treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 31/192 (2006.01) A61K 31/216 (2006.01) A61K 31/335 (2006.01) A61K 31/426 (2006.01) A61K 31/505 (2006.01) A61K 31/7088 (2006.01) A61P 27/06 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2545777

The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents that modulate the expression of serum amyloid A.

La présente invention concerne des compositions et des méthodes de traitement du glaucome ainsi que des méthodes d'identification d'agents pouvant convenir pour le traitement du glaucome. Plus précisément, cette invention concerne l'emploi d'agents qui modulent l'expression de l'amyloïde sérique A.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of serum amyloid a gene in diagnosis and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of serum amyloid a gene in diagnosis and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of serum amyloid a gene in diagnosis and treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1807806

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.